Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Pliant Therapeutics, Inc. Common Stock (PLRX)

Pharmaceutical Preparations

https://www.pliantrx.com

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

260 LITTLEFIELD AVENUE
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/03/2020

Market Cap

762,145,549

Shares Outstanding

59,900,000

Weighted SO

59,895,958

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

RLAY --.--%

STOK --.--%

BDTX --.--%

ARVN --.--%

ETNB --.--%

MDGL --.--%

ACLX --.--%

DYN --.--%

CYTK --.--%

Beta

1.1580

Last Div

0.0000

Range

10.29-19.62

Chg

0.1050

Avg Vol

604619

Mkt Cap

762145549

Exch

NASDAQ

Country

US

Phone

650 481 6770

DCF Diff

11.7092

DCF

0.8358

Div Yield

0.0000

P/S

157.4682

EV Multiple

-3.5992

P/FV

1.9275

Div Yield %

0.0000

P/E

-4.0824

PEG

-0.8427

Payout

0.0000

Current Ratio

14.4727

Quick Ratio

14.4727

Cash Ratio

2.5995

DSO

211.3834

DIO

0.0000

Op Cycle

211.3834

DPO

448.2434

CCC

-236.8600

Gross Margin

0.4537

Op Margin

-42.9242

Pretax Margin

-38.3068

Net Margin

-38.3068

Eff Tax Rate

-0.0184

ROA

-0.3833

ROE

-0.4105

ROCE

-0.4588

NI/EBT

1.0000

EBT/EBIT

0.8924

EBIT/Rev

-42.9242

Debt Ratio

0.0624

D/E

0.0768

LT Debt/Cap

0.0711

Total Debt/Cap

0.0713

Int Coverage

-16.0625

CF/Debt

-4.5377

Equity Multi

1.2319

Rec Turnover

1.7267

Pay Turnover

0.8143

Inv Turnover

0.0000

FA Turnover

0.1413

Asset Turnover

0.0100

OCF/Share

-2.2671

FCF/Share

-2.3151

Cash/Share

7.2307

OCF/Sales

-28.2839

FCF/OCF

1.0212

CF Coverage

-4.5377

ST Coverage

-1396.8776

CapEx Coverage

-47.2374

Div&CapEx Cov

-47.2374

P/BV

1.9275

P/B

1.9275

P/S

157.4682

P/E

-4.0824

P/FCF

-5.4520

P/OCF

-5.5291

P/CF

-5.5291

PEG

-0.8427

P/S

157.4682

EV Multiple

-3.5992

P/FV

1.9275

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Feb 07, 21:58 Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis Investing.com Jul 13, 01:35 Pliant Therapeutics CBO sells shares worth over $114k - Investing.com

Revenue Product Segmentation